Sinikka Green, Principal Investigator and Medical Director at Care Access
This triple-receptor activity profile makes the retatrutide research compound particularly valuable for studies exploring energy homeostasis, metabolic regulation, receptor binding kinetics, and downstream signaling cascades
Previous antiobesity medications showed modest efficacy with limited long-term safety data and limited benefits beyond weight loss
Wharton et al., Lancet Diabetes Endocrinol
5.6 Severe Gastrointestinal Adverse Reactions SPL UNCLASSIFIED SECTION Use of WEGOVY has been associated with gastrointestinal adverse reactions, sometimes severe [see Adverse Reactions (6)]
Every appointment begins with a genuine conversation about your goals so your treatment plan feels customized, purposeful, and suited to your comfort level